CAMHS medication related guidance
-
Medicines management temporary changes during the Covid-19 pandemic- May 20
-
Rapid Tranquilisation, medication (including oral) guidelines in the context of the Covid 19 pandemic - Apr 20
-
Clozapine, advice for healthcare professionals during the Covid-19 crisis - Mar 20
-
Clozapine, advice for patient during the Covid-19 pandemic - Mar 20
-
Valproate, temporary MHRA Covid-19 guidelines on the valproate pregnancy prevention programme - May 20
-
FP10s, remote prescribing for commuity patients during the Covid-19 pandemic - Apr 20
-
Clozapine, procedure and guidelines for the use - Apr 15
-
Rapid Tranquillisation Policy - Oct 18
-
Guanfacine prescribing guidance - Aug 17
-
Hyperprolactinaemia, guidelines on the treatment of antipsychotic induced hyperprolactinaemia - Jul 16
-
GP information - checklist of medication related information requested by GPs in clinic correspondence and discharge summaries - CAMHS version - Apr 16
-
Sussex Partnership Trust Formulary - July 20
-
Mood stabilizer guidelines for the treatment of bipolar affective disorder - Feb 16
-
Non-drug/illegal drug interactions with psychotropic drugs - Feb 14
-
Non medical prescribing policy
-
Medicines Code 2019-20
-
GP information - checklist of medication related information requested by GPs in clinic correspondence and discharge summaries - adult version - Jan 18
-
Glasgow Antipsychotic Side-effect Scale questionnaire (GASS) - Jan 18
-
Glasgow Antipsychotic Side-effect Scale (GASS) publication paper, Taylor et al - 2008
-
Cost Effective Prescribing tips for CAMHS Teams – Apr 18
-
Antipsychotics, guidelines for use - Jun 18
-
Antidepressants in Children and Adolescents, guidance on the use of - Dec 18
-
Antidepressant side-effect checklist - notes on use - Aug 15
-
Antidepressant side-effect checklist - Aug 15
-
FP10s, flow chart for lost or stolen prescription pads - Jun 20